Regina Skavron is a team leader (non-oncology products) and Senior Scientific Adviser at the Federal Joint Committee (G-BA) in Germany. She graduated from the Medical School at the University of Cologne, Germany. Regina obtained her M.Sc. in "Health Policy, Planning and Financing" from the London School of Economics and the London School of Hygiene & Tropical Medicine. Dr Skavron joined the G-BA in 2007. She has since been a Scientific Adviser in the Pharmaceuticals Department and has been involved in the AMNOG procedure from its inception.

The team under her lead is responsible for all non-oncology products in Germany. She is involved in the decision making process following the assessments as well as the consultations of pharmaceutical companies.